6:28 PM
Nov 13, 2012
 |  BC Extra  |  Company News

GSK, Imagine Institute partner for rare disease

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) partnered with the Imagine Institute to discover and develop compounds to treat Netherton syndrome, a rare inherited skin disorder characterized by chronic skin inflammation,...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >